Table 5.
Comparison of short-term oncological outcomes by robotic-assisted TMEa
| Study | Country (year) | Local recurrence (%) | Distant metastasis (%) | Disease-free survival | Overall survival |
|---|---|---|---|---|---|
| Present study (Huang et al.) | Taiwan (2017) | 2.4 | 14.5 | 83.0% (2–year) | 95.0% (2–year) |
| Pai et al. [35] | USA (2015) | 4 | 17 | 79.2% (3–year) | 90.1% (3–year) |
| Kim et al. [36] | Korea (2016) | 1.9 | 26.4 | 72.8% (4–year) | 87.7% (4–year) |
| Feroci et al. [37] | Italy (2016) | 1.9 | 17 | 79.2% (3–year) | 90.2% (3–year) |
| Cho et al. [38] | Korea (2012) | 1.8 | 12.2 | 81.8% (5–year) | 92.2% (5–year) |
| Park et al. [40] | Korea (2015) | 2.3 | 12.0 | 81.9% (5–year) | 92.8% (5–year) |
| Ghezzi et al. [41] | Brazil/Italy (2014) | 3.2 | 18.5 | 73.2% (5–year) | 85.2% (5–year) |
| Hara et al. [43] | Korea (2014) | 4.5 | 10 | 81.7% (5–year) | 92.0% (5–year) |
| Bail et al. [44] | Korea (2013) | 3.6 | 17.6 | 79.2% (3–year) | 93.1% (3–year) |
a TME total mesorectal excision